KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Sarepta Therapeutics (SRPT) EPS (Basic): 2011-2024

Historic EPS (Basic) for Sarepta Therapeutics (SRPT) over the last 14 years, with Dec 2024 value amounting to $2.47.

  • Sarepta Therapeutics' EPS (Basic) fell 1305.26% to -$4.58 in Q2 2025 from the same period last year, while for Jun 2025 it was -$2.18, marking a year-over-year decrease of 303.85%. This contributed to the annual value of $2.47 for FY2024, which is 142.59% up from last year.
  • According to the latest figures from FY2024, Sarepta Therapeutics' EPS (Basic) is $2.47, which was up 142.59% from -$5.80 recorded in FY2023.
  • Sarepta Therapeutics' EPS (Basic)'s 5-year high stood at $2.47 during FY2024, with a 5-year trough of -$8.03 in FY2022.
  • Moreover, its 3-year median value for EPS (Basic) was -$5.80 (2023), whereas its average is -$3.79.
  • Per our database at Business Quant, Sarepta Therapeutics' EPS (Basic) slumped by 55.92% in 2022 and then skyrocketed by 142.59% in 2024.
  • Over the past 5 years, Sarepta Therapeutics' EPS (Basic) (Yearly) stood at -$7.11 in 2020, then climbed by 27.57% to -$5.15 in 2021, then crashed by 55.92% to -$8.03 in 2022, then rose by 27.77% to -$5.80 in 2023, then spiked by 142.59% to $2.47 in 2024.